参考文献/References:
[1] AMBROSI F,RIGHI A,RICCI C,et al.Hobnail variant of papillary thyroid carcinoma:a literature review[J].Endocr Pathol,2017,28(4):293-301.
[2] SEETHALA R R,BALOCH Z W,BARLETTA J A,et al.Noninvasive follicular thyroid neoplasm with papillary-like nuclear features:a review for pathologists[J].Mod Pathol,2018,31(1):39-55.
[3] FUJII Y R.Quantum language of microRNA:application for new cancer therapeutic targets[J].Methods Mol Biol,2018,12(1733):145-157.
[4] MULLANY L E,HERRICK J S,WOLFF R K,et al.MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases[J].Genes Chromosomes Cancer,2018,57(4):192-203.
[5] 韩友霞,樊桂萍,季葆华,等.甲状腺乳头状癌相关致病基因及microRNAs的筛选和生物信息学分析[J].基因组学与应用生物学,2017,36(11):4419-4431.
[6] 兰雨,宋青,金壮,等.常规超声特征及BRAFV600E基因突变与甲状腺乳头状癌颈部淋巴结转移的相关性[J].解放军医学杂志,2019,44(9):747-752.
[7] NATH M C,ERICKSON L A.Aggressive variants of papillary thyroid carcinoma:hobnail,tall cell,columnar,and solid[J].Adv Anat Pathol,2018,25(3):172-179.
[8] 崔科英,何建苗,邱啸臣,等.甲状腺乳头状癌规范化手术治疗的临床特点分析[J].解放军医学杂志,2019,44(11):964-967.
[9] 朱斌路,姜红堃.竞争性内源RNA与心血管疾病发病机制的研究进展[J].中华实用儿科临床杂志,2018,33(13):1033-1036.
[10] 牛连杰,张雅敏.MicroRNA在肝癌干细胞中的作用研究进展[J].中华肝胆外科杂志,2018,24(9):641-645.
[11] 邓玉颖,欧阳伟.MicroRNA在甲状腺乳头状癌中的作用研究进展[J].广东医学,2018,39(13):2078-2081.
[12] 王玉君,林秀艳,王涛.miR-582-5p靶向调控AKT3对甲状腺乳头状癌细胞增殖和凋亡的影响[J].新乡医学院学报,2018,35(11):954-960.
[13] 胡仿玲,张思林,余杰情,等.MicroRNA作为甲状腺乳头状癌生物标记物的研究进展[J].临床耳鼻咽喉头颈外科杂志,2018,467(15):80-83.
[14] 曹双双,解丹,梁义娟.miRNA-152在子宫内膜癌中的研究进展[J].中国生育健康杂志,2019,30(2):196-198.
[15] ZENG K,HE B,YANG B B,et al.The pro-metastasis effect of circANKS1B in breast cancer[J].Mol Cancer,2018,17(1):160-178.
[16] FRIEDRICH M,PRACHT K,MASHREGHI M F,et al.The role of the miR-148/-152 family in physiology and disease[J].Eur J Immunol,2017,47(12):2026-2038.
[17] XIE D,LIANG Y,SU Y,et al.miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by suppressing CDC25B expression[J].Biomed Pharmacother,2018,3(99):299-305.
[18] 周文宾,毕兴杰,孙立江.MiRNA-148b和miRNA-152通过KIT/AKT信号通路诱导人肾癌细胞凋亡[J].免疫学杂志,2016,32(11):947-952.
[19] HE W,HUANG L,LI M,et al.MiR-148b,miR-152/ALCAM axis regulates the proliferation and invasion of pituitary adenomas cells[J].Cell Physiol Biochem,2017,42(2):792-803.
[20] BROWMAN D T,RESEK M E,ZAJCHOWSKI L D,et al.Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER[J].J Cell Sci,2006,119(15):3149-3160.
[21] WHITTEN-BAUER C,CHUNG J,GMEZ-MORENO A,et al.The host factor erlin-1 is required for efficient hepatitis C virus infection[J].Cell,2019,8(12):1555-1563.
[22] 吴贺文.miR-410通过靶定ERLIN1调控乳腺癌生长侵袭和转移[D].郑州:郑州大学,2017.
相似文献/References:
[1]王玉君,林秀艳,王 涛.miR-582-5p靶向调控AKT3对甲状腺乳头状癌细胞增殖和凋亡的影响[J].新乡医学院学报,2018,35(11):954.[doi:10.7683/xxyxyxb.2018.11.003]
WANG Yu-jun,LIN Xiu-yan,WANG Tao.Effect of miR-582-5p targeting AKT3 on proliferation and apoptosis of papillary thyroid carcinoma cells[J].Journal of Xinxiang Medical University,2018,35(9):954.[doi:10.7683/xxyxyxb.2018.11.003]
[2]郭艳风,韩芳毅,周红艳,等.L型氨基酸转运体1和血管内皮生长因子在甲状腺乳头状癌中的表达及意义[J].新乡医学院学报,2017,34(1):036.[doi:10.7683/xxyxyxb.2017.01.010]
GUO Yan-feng,HAN Fang-yi,ZHOU Hong-yan,et al.Expressions of L-type amino acid transporter 1 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinical significance[J].Journal of Xinxiang Medical University,2017,34(9):036.[doi:10.7683/xxyxyxb.2017.01.010]